InnovAge (INNV) vs Omada Health (OMDA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
InnovAge (INNV) has outperformed Omada Health (OMDA) over the past year, gaining 74.5% versus a loss of 36.2%. InnovAge is the larger company by market cap ($1.25 billion vs $736.4 million), about 1.7 times the size, while Omada Health is growing revenue faster (+53.2% vs +15.9%). On valuation, Omada Health trades at a lower forward P/E (17.2x vs 18.3x for InnovAge).
InnovAge converts more of its revenue into profit, with a net margin of -0.3% versus -4.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INNV | OMDA |
|---|---|---|
| Share price | $9.16 | $11.87 |
| Market cap | $1.25B | $736.39M |
| 1-day change | +2.81% | -5.04% |
| YTD return | +76.49% | -24.78% |
| 1-year return | +74.48% | -36.18% |
| 5-year return | +20.37% | — |
| P/E ratio (TTM) | 152.67 | 29.68 |
| Forward P/E | 18.32 | 17.18 |
| EPS (TTM) | $0.06 | $0.40 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $989.71M | $260.21M |
| Revenue growth (YoY) | +15.93% | +53.24% |
| Net income (latest FY) | $-2.54M | $-12.78M |
| Gross margin | 23.01% | 65.69% |
| Operating margin | 0.26% | -4.60% |
| Net margin | -0.26% | -4.91% |
| 52-week high | $12.64 | $25.45 |
| 52-week low | $4.70 | $10.28 |
| Distance from 52-week high | -27.53% | -53.36% |
| Analyst consensus | none | buy |
| Avg. price target upside | +31.00% | +123.25% |
| Average volume | 595.71K | 1.33M |
| Shares outstanding | 136.46M | 62.04M |
| Employees | 2,500 | 980 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- INNV has outperformed OMDA by 110.7 percentage points over the past year.
- InnovAge trades at a higher earnings multiple (152.7x vs 29.7x trailing P/E).
- Omada Health grew revenue faster in its latest fiscal year (+53.24% vs +15.93%).
About InnovAge
INNV stock →InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors.
Health Care · Medical/Nursing Services · 2,500 employees
About Omada Health
OMDA stock →Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs.
Health Care · Medical/Nursing Services · 980 employees
INNV vs OMDA FAQ
Which is bigger, InnovAge or Omada Health?
InnovAge (INNV) is larger, with a market capitalization of $1.25B compared with $736.39M for Omada Health (OMDA).
Which stock has performed better over the past year, INNV or OMDA?
INNV returned +74.48% over the past 12 months, compared with -36.18% for OMDA (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, INNV or OMDA?
OMDA has the lower trailing P/E at 29.7, versus 152.7 for INNV. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are InnovAge and Omada Health in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.